IMRIS (IMRSQ) OCF Margin %: -19.43% (As of Dec. 2014)


What is IMRIS OCF Margin %?

IMRIS IMRSQ OCF Margin % is -19.43% as of Dec. 2014.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. IMRIS's Cash Flow from Operations for the three months ended in Dec. 2014 was $-1.86 Mil. IMRIS's Revenue for the three months ended in Dec. 2014 was $9.56 Mil. Therefore, IMRIS's OCF Margin % for the quarter that ended in Dec. 2014 was -19.43%.

As of today, IMRIS's current OCF Yield % is 0.00%.

The historical rank and industry rank for IMRIS's OCF Margin % or its related term are showing as below:

IMRSQ' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -37.76

IMRSQ's OCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 5.86 vs IMRSQ: -37.76

IMRIS OCF Margin % Related Terms

IMRIS OCF Margin % Historical Data

* Premium members only.

The historical data trend for IMRIS's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMRIS OCF Margin % Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
OCF Margin %
Get a 7-Day Free Trial Premium Member Only -20.17 -34.60 -29.85 -88.14 -37.76

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -133.20 10.76 -74.07 -97.86 -19.43

IMRSQ vs IVOB, IGNG, IRIX: OCF Margin % Comparison

For the Medical Devices subindustry, IMRIS's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IMRIS OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IMRIS's OCF Margin % distribution charts can be found below:

* The bar in red indicates where IMRIS's OCF Margin % falls into.


IMRIS OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

IMRIS's OCF Margin for the fiscal year that ended in Dec. 2014 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2014 )/Revenue (A: Dec. 2014 )
=-10.91/28.891
=-37.76 %

IMRIS's OCF Margin for the quarter that ended in Dec. 2014 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2014 )/Revenue (Q: Dec. 2014 )
=-1.857/9.558
=-19.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -19.43% mean?
IMRIS (IMRSQ) has a OCF Margin % of -19.43% as of Dec. 2014. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on IMRIS and its competitors.
Is IMRIS's OCF Margin % too high?
IMRIS's current OCF Margin % is -19.43%.
How does IMRIS's OCF Margin % compare to IVOB and IGNG?
IMRIS's OCF Margin % of -19.43% can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on IMRIS and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMRIS's current OCF Margin % is -19.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMRIS stock overvalued right now?
IMRIS (IMRSQ) has a current OCF Margin % of -19.43%. The current OCF Margin % is -19.43%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For IMRIS (IMRSQ), the current OCF Margin % is -19.43% as of Dec. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMRIS Business Description

Address 1230 Chaska Creek Way, Suite 100, Chaska, MN, USA, 55318
IMRIS Inc provides integrated intraoperative imaging environments that deliver real-time MRI and imaging data during surgical and interventional procedures. The Operating Suite of the company enables imaging directly within the OR, enhancing clinical decision-making. The company also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables tailored for this specialized setting.